13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35121040 | Human cytochrome P450 3A-mediated two-step oxidation metabolism of dimethomorph: Implications in the mechanism-based enzyme inactivation. | 2022 May 20 | 1 |
2 | 35139477 | Synthesis and evaluation of tofacitinib analogs designed to mitigate metabolic activation. | 2022 Apr | 1 |
3 | 35512804 | Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of Cytochrome P450 3A. | 2022 May 5 | 2 |
4 | 33436520 | Mechanism-Based Inactivation of Cytochrome P450 3A4 by Benzbromarone. | 2021 Apr | 1 |
5 | 34326139 | Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4. | 2021 Sep | 1 |
6 | 31485694 | Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes. | 2020 Feb | 1 |
7 | 31833760 | "Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4": Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping. | 2020 Feb 17 | 2 |
8 | 32469513 | Reply to Letter to Editor from Veeravalli and Dash on "Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4: Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping". | 2020 Jul 20 | 1 |
9 | 30142320 | The critical role of porcine cytochrome P450 3A46 in the bioactivation of aflatoxin B1. | 2018 Oct | 1 |
10 | 15572649 | Predictive models of CYP3A4 Heteroactivation: in vitro-in vivo scaling and pharmacophore modeling. | 2005 Mar | 1 |
11 | 14672753 | Herbal bioactivation: the good, the bad and the ugly. | 2004 Jan 9 | 1 |
12 | 12397847 | Pharmacokinetics of mood stabilizers and new anticonvulsants. | 2002 Winter | 1 |
13 | 8261428 | Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. | 1994 Jan 1 | 1 |